Trazodone is triazolopyridine derivative from the serotonin receptor antagonists and reuptake inhibitors (SARIs) class of antidepressants. It is used in adults and has been shown to be comparable in efficacy to other drugs such as tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and serotonin-norepinephrine receptor inhibito...
Trazodone is indicated for the treatment of major depressive disorder (MDD). It has been used off-label for adjunct therapy in alcohol dependence, and off-label to treat anxiety and insomnia. It may also be used off-label to treat symptoms of dementia, Alzheimer’s disease, schizophrenia, eating disorders, and fibromyalgia due to its effects on various neurot...
Chang Gung Memorial Hospital, Keelung, Keelung, Taiwan
Psychiatric University Hospital, Zürich, ZH, Switzerland
Birmingham VA Medical Center, Birmingham, AL, Birmingham, Alabama, United States
Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa, Alabama, United States
Phoenix VA Health Care System, Phoenix, AZ, Phoenix, Arizona, United States
Northwest Kidney Centers, Seattle, Washington, United States
CHUM, Montréal, Quebec, Canada
Northwestern University, Chicago, Illinois, United States
Ann and Robert H. Lurie Childrens Hospital of Chicago, Chicago, Illinois, United States
Loma Linda University Health, Loma Linda, California, United States
Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, United States
John D. Dingell VA Medical Center, Detroit, Michigan, United States
University of California San Diego, San Diego, California, United States
Jacobi Medical Center, Bronx, New York, United States
University of Rochester, Rochester, New York, United States
Honor Health, Scottsdale, Arizona, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.